2-(3-Bromo-5-methylphenyl)morpholine, 97%, 100mg

Methyl 2-amino-6-methoxynicotinate, 95.0%, 250mg

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-inden-1-one, 95.0%, 100mg

4,5-Dichloro-3-methylthiophene-2-carboxylic acid, 95%, 250mg

4-Quinazolinamine, 6,7-dimethoxy-2-(1-pyrrolidinyl)-N-[5-(1-pyrrolidinyl)pentyl]-, 100mg

2-Chloro-quinoline, 95.0%, 5g

5-Bromo-1-isopropyl-1H-indazole, 95.0%, 1g

Colonne di guardia HPLC (analitiche) NUCLEODUR® NH2-RP 5 µm, 4x3 mm, 3 Pezzo(i)

Ethyl (S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylate hydrochloride, 95%, 5g

2-(tert-Butoxycarbonyl)-2,6-diazaspiro[3.4]octane-8-carboxylic acid, 98%, 500mg

2,5-Dimethoxy-4-formylbenzoic acid, 98%, 5g

1-(3-chlorobenzoyl)-1,4-diazepane, 95.0%, 2g

3-Oxa-8-aza-bicyclo[3.2.1]octane, 95.0%, 1g